ML16039A182: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
(Created page by program invented by StriderTol)
 
Line 17: Line 17:


=Text=
=Text=
{{#Wiki_filter:UNIVERSITY of MISSOURI RESEARCH REACTOR CENTER January 26, 2016 Mr. Alexander Adams Jr.U.S. Nuclear Regulatory Commission Mail Stop O12-G13 Washington, DC 20555-0001
{{#Wiki_filter:UNIVERSITY of MISSOURI RESEARCH REACTOR CENTER January 26, 2016 Mr. Alexander Adams Jr.
U.S. Nuclear Regulatory Commission Mail Stop O12-G13 Washington, DC 20555-0001


==Subject:==
==Subject:==
Notice that the University of Missouri Research Reactor intends to submit a license amendment in support of NorthWest Medical Isotopes, Inc.'s Molybdenum 99 Project The purpose of this letter is to provide notice that the University of Missouri Research Reactor (MURR) intends to submit a license amendment for the purpose of irradiating Low Enriched Uranium (LEU) targets in the reflector region of the MURR in support of NorthWest Medical Isotopes, Inc. (NWMI) molybdenum 99 (9 9 M0) project during calendar year 2016.While this project is currently in the conceptual design stage, MURR wishes to provide early notice of our intent for NRC resource planning purposes to help assure the efficiency of the regulatory licensing process. We anticipate that this project will require a license amendment to our Reactor License (Class 104c Amended Facility License No. R-103, Docket No. 50-186).If you have any questions, please contact me at 573-882-4211.
Notice that the University of Missouri Research Reactor intends to submit a license amendment in support of NorthWest Medical Isotopes, Inc.'s Molybdenum 99 Project The purpose of this letter is to provide notice that the University of Missouri Research Reactor (MURR) intends to submit a license amendment for the purpose of irradiating Low Enriched Uranium (LEU) targets in the reflector region of the MURR in support of NorthWest Medical Isotopes, Inc. (NWMI) molybdenum 99 (99 M0) project during calendar year 2016.
Sincerely, Ralph A. Butler Executive Director 1513 Research Park Drive Columbia, MO 65211 Phone: 573-882-4211 Fax: 573-882-6360 Web: www.murr.missouri.edu Fighting Cancer with Tomorrow s Technology UNIVERSITY of MISSOURI RESEARCH REACTOR CENTER January 26, 2016 Mr. Alexander Adams Jr.U.S. Nuclear Regulatory Commission Mail Stop O12-G13 Washington, DC 20555-0001
While this project is currently in the conceptual design stage, MURR wishes to provide early notice of our intent for NRC resource planning purposes to help assure the efficiency of the regulatory licensing process. We anticipate that this project will require a license amendment to our Reactor License (Class 104c Amended Facility License No. R-103, Docket No. 50-186).
If you have any questions, please contact me at 573-882-4211.
Sincerely, Ralph A. Butler Executive Director 1513 Research Park Drive Columbia, MO 65211 Phone: 573-882-4211 Fax: 573-882-6360 Web: www.murr.missouri.edu Fighting Cancer with Tomorrow s Technology
 
UNIVERSITY of MISSOURI RESEARCH REACTOR CENTER January 26, 2016 Mr. Alexander Adams Jr.
U.S. Nuclear Regulatory Commission Mail Stop O12-G13 Washington, DC 20555-0001


==Subject:==
==Subject:==
Notice that the University of Missouri Research Reactor intends to submit a license amendment in support of NorthWest Medical Isotopes, Inc.'s Molybdenum 99 Project The purpose of this letter is to provide notice that the University of Missouri Research Reactor (MURR) intends to submit a license amendment for the purpose of irradiating Low Enriched Uranium (LEU) targets in the reflector region of the MURR in support of NorthWest Medical Isotopes, Inc. (NWMI) molybdenum 99 (9 9 M0) project during calendar year 2016.While this project is currently in the conceptual design stage, MURR wishes to provide early notice of our intent for NRC resource planning purposes to help assure the efficiency of the regulatory licensing process. We anticipate that this project will require a license amendment to our Reactor License (Class 104c Amended Facility License No. R-103, Docket No. 50-186).If you have any questions, please contact me at 573-882-4211.
Notice that the University of Missouri Research Reactor intends to submit a license amendment in support of NorthWest Medical Isotopes, Inc.'s Molybdenum 99 Project The purpose of this letter is to provide notice that the University of Missouri Research Reactor (MURR) intends to submit a license amendment for the purpose of irradiating Low Enriched Uranium (LEU) targets in the reflector region of the MURR in support of NorthWest Medical Isotopes, Inc. (NWMI) molybdenum 99 (99 M0) project during calendar year 2016.
While this project is currently in the conceptual design stage, MURR wishes to provide early notice of our intent for NRC resource planning purposes to help assure the efficiency of the regulatory licensing process. We anticipate that this project will require a license amendment to our Reactor License (Class 104c Amended Facility License No. R-103, Docket No. 50-186).
If you have any questions, please contact me at 573-882-4211.
Sincerely, Ralph A. Butler Executive Director 1513 Research Park Drive Columbia, MO 65211 Phone: 573-882-4211 Fax: 573-882-6360 Web: www.murr.missouri.edu Fighting Cancer with Tomorrow s Technology}}
Sincerely, Ralph A. Butler Executive Director 1513 Research Park Drive Columbia, MO 65211 Phone: 573-882-4211 Fax: 573-882-6360 Web: www.murr.missouri.edu Fighting Cancer with Tomorrow s Technology}}

Latest revision as of 00:50, 31 October 2019

Univ. of Missouri-Columbia - Notice of Intention to Submit License Amendment in Support of North Wes Medical Isotope, Inc.'S Molybdenum 99 Project
ML16039A182
Person / Time
Site: University of Missouri-Columbia
Issue date: 01/26/2016
From: Rhonda Butler
Univ of Missouri - Columbia
To: Alexander Adams
Document Control Desk, Office of Nuclear Reactor Regulation
References
Download: ML16039A182 (1)
v • d • e


Text

UNIVERSITY of MISSOURI RESEARCH REACTOR CENTER January 26, 2016 Mr. Alexander Adams Jr.

U.S. Nuclear Regulatory Commission Mail Stop O12-G13 Washington, DC 20555-0001

Subject:

Notice that the University of Missouri Research Reactor intends to submit a license amendment in support of NorthWest Medical Isotopes, Inc.'s Molybdenum 99 Project The purpose of this letter is to provide notice that the University of Missouri Research Reactor (MURR) intends to submit a license amendment for the purpose of irradiating Low Enriched Uranium (LEU) targets in the reflector region of the MURR in support of NorthWest Medical Isotopes, Inc. (NWMI) molybdenum 99 (99 M0) project during calendar year 2016.

While this project is currently in the conceptual design stage, MURR wishes to provide early notice of our intent for NRC resource planning purposes to help assure the efficiency of the regulatory licensing process. We anticipate that this project will require a license amendment to our Reactor License (Class 104c Amended Facility License No. R-103, Docket No. 50-186).

If you have any questions, please contact me at 573-882-4211.

Sincerely, Ralph A. Butler Executive Director 1513 Research Park Drive Columbia, MO 65211 Phone: 573-882-4211 Fax: 573-882-6360 Web: www.murr.missouri.edu Fighting Cancer with Tomorrow s Technology

UNIVERSITY of MISSOURI RESEARCH REACTOR CENTER January 26, 2016 Mr. Alexander Adams Jr.

U.S. Nuclear Regulatory Commission Mail Stop O12-G13 Washington, DC 20555-0001

Subject:

Notice that the University of Missouri Research Reactor intends to submit a license amendment in support of NorthWest Medical Isotopes, Inc.'s Molybdenum 99 Project The purpose of this letter is to provide notice that the University of Missouri Research Reactor (MURR) intends to submit a license amendment for the purpose of irradiating Low Enriched Uranium (LEU) targets in the reflector region of the MURR in support of NorthWest Medical Isotopes, Inc. (NWMI) molybdenum 99 (99 M0) project during calendar year 2016.

While this project is currently in the conceptual design stage, MURR wishes to provide early notice of our intent for NRC resource planning purposes to help assure the efficiency of the regulatory licensing process. We anticipate that this project will require a license amendment to our Reactor License (Class 104c Amended Facility License No. R-103, Docket No. 50-186).

If you have any questions, please contact me at 573-882-4211.

Sincerely, Ralph A. Butler Executive Director 1513 Research Park Drive Columbia, MO 65211 Phone: 573-882-4211 Fax: 573-882-6360 Web: www.murr.missouri.edu Fighting Cancer with Tomorrow s Technology

Retrieved from "https://kanterella.com/w/index.php?title=ML16039A182&oldid=2024132"